emoxypine succinate has been researched along with Alloxan Diabetes in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 5 (83.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Miroshnichenko, IY; Rassokhina, LM; Volchegorskii, IA | 1 |
Faizullin, RM; Kalugina, AV; Miroshnichenko, IY; Pryakhina, KE; Rassokhina, LM; Volchegorskii, LA | 1 |
Bukina, SJ; Inchina, VI | 1 |
Miroshnichenko, IIu; Rassokhina, LM; Volchegorskiĭ, IA | 2 |
Slietsans, AA; Snigur, GL; Tiurenkov, IN; Voronkov, AV | 1 |
6 other study(ies) available for emoxypine succinate and Alloxan Diabetes
Article | Year |
---|---|
Cerebroprotective effects of emoxipin, reamberin, and mexidol in alloxan diabetes.
Topics: Alloxan; Animals; Astrocytes; Cerebral Cortex; Diabetes Mellitus, Experimental; Diencephalon; Female; Hippocampus; Hyperglycemia; Male; Meglumine; Neurons; Neuroprotective Agents; Oligodendroglia; Paraventricular Hypothalamic Nucleus; Picolines; Rats; Succinates; Thioctic Acid | 2013 |
[Anxiolytic and antidepressant effects of 3-oxypiridine and succinic acid derivatives in alloxan diabetes].
Topics: Animals; Anti-Anxiety Agents; Anxiety; Depression; Diabetes Mellitus, Experimental; Humans; Hyperglycemia; Meglumine; Picolines; Pyridines; Rats; Succinates; Succinic Acid; Thioctic Acid | 2015 |
Neuroprotective activity of mexidole and 3-hydroxypyridine acetylcysteinate against the background of cerebral ischemia in the complex of experimental diabetes mellitus and exogenous hypercholesterolemia.
Topics: Acetylcysteine; Animals; Brain Ischemia; Diabetes Mellitus, Experimental; Female; Hypercholesterolemia; Male; Neuroprotective Agents; Picolines; Rats; Treatment Outcome | 2008 |
[Cerebroprotective effect of 3-oxypyridine and succinic acid derivatives in acute phase of alloxan-induced diabetes mellitus in rats].
Topics: Alloxan; Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Disease Models, Animal; Female; Hippocampus; Learning; Lipid Metabolism; Lipid Peroxidation; Male; Meglumine; Motor Activity; Neurons; Neuroprotective Agents; Nootropic Agents; Picolines; Pyridines; Rats; Succinates; Succinic Acid; Thioctic Acid | 2011 |
[Antihypoxic effect of 3-hydroxypyridine and succinic acid derivatives and their nootropic action in alloxan diabetes].
Topics: Alloxan; Animals; Conditioning, Classical; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Dose-Response Relationship, Drug; Female; Hyperglycemia; Hyperlipidemias; Hypoxia; Male; Meglumine; Mice; Nootropic Agents; Picolines; Pyridines; Rats; Succinates; Thioctic Acid | 2011 |
[Effects of mexidol and sulodexide on the level of specific markers of endothelial dysfunction in animals with experimental diabetes mellitus].
Topics: Animals; Biomarkers; Blood Glucose; Diabetes Mellitus, Experimental; Endothelin-1; Endothelium; Glycosaminoglycans; Immunohistochemistry; Male; Nitric Oxide Synthase Type III; Picolines; Rats; Vascular Diseases | 2012 |